サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1513443

着床前遺伝子診断の世界市場規模調査：検査タイプ別、地域別、2022年～2032年の予測

Global Preimplantation Genetic Diagnosis Market Size Study, by Test Type (Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single Gene Disorders, HLA Typing, Gender selection, Others) and Regional Forecasts 2022-2032

出版日
ページ情報
英文 200 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
着床前遺伝子診断の世界市場規模調査：検査タイプ別、地域別、2022年～2032年の予測
出版日: 2024年07月09日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の着床前遺伝子診断市場は、2023年に約7,212万米ドルと評価され、予測期間2024-2032年には11.41%以上の健全な成長率で成長すると予測されています。

着床前遺伝子診断（PGD）は、体外受精（IVF）とともに使用される高度な生殖技術で、着床前に胚の遺伝的状態をスクリーニングします。このプロセスにより、遺伝性疾患を受け継ぐリスクのあるカップルが健康な子供を持つ可能性を高めることができます。体外受精のプロセスでは、ホルモン治療、採卵、ラボでの受精、胚盤胞期までの胚培養を行い、そこで細胞を生検して遺伝子異常を分析します。異常のない胚が子宮への移植用に選択されます。PGDは遺伝子異常の感染を減らし、体外受精の成功率を高め、倫理的な配慮を促します。遺伝性疾患の家族歴、反復流産、不妊症の問題を抱えるカップルにとって有益です。着床前遺伝子診断の世界市場は、遺伝性疾患に対する認識の高まり、生殖技術の進歩、体外受精の受け入れ率の上昇、政府による支援的規制などにより拡大しています。また、親になるのが遅れる傾向や不妊率の上昇もPGDの需要に寄与しており、市場の成長を後押ししています。

世界の着床前遺伝子診断（PGD）市場は、遺伝性疾患に対する意識の高まり、生殖技術の進歩、遺伝性疾患の有病率の上昇、体外受精の受け入れ拡大が牽引しています。次世代シーケンシングなどの技術革新により、PGDの精度と効率が向上し、遺伝子異常の幅広い検出が可能になり、着床不全や流産のリスクが減少しています。これらの進歩により、PGDはより信頼性が高く、利用しやすくなり、より多くのカップルがより健康な子孫を残すためにこの技術を利用するようになった。しかしながら、高額な費用、胚選択に関する倫理的懸念、両親への心理的影響が大きな障壁となっています。さらに、新興諸国では高度生殖医療技術へのアクセスが限られており、国によって法的・倫理的ガイドラインが異なることも課題となっています。このような状況にもかかわらず、政府の規制や遺伝子研究への資金援助は市場の成長に寄与しており、PGDは次世代の健康を確保するための貴重なツールとなっています。

着床前遺伝子診断の世界市場調査において考慮した主な地域は、アジア太平洋地域、北米、欧州、ラテンアメリカ、その他世界のその他の地域です。北米は、着床前遺伝子診断（PGD）世界市場において、収益面で支配的な地域です。同地域は高度なヘルスケアインフラを誇り、最先端の生殖技術へのアクセスを広く可能にしています。着床前遺伝子診断（PGD）および体外受精の導入率が高いのは、遺伝性疾患に対する意識の高まりと、親になる見込みのある人々の間で早期の遺伝子スクリーニングが有益であることが背景にあります。研究開発への多額の投資は、政府の支援政策や資金援助と相まって、遺伝子検査法の絶え間ない革新と改善を促進しています。大手バイオテクノロジー企業や一流の不妊治療クリニックの存在が、北米市場の地位をさらに高めています。一方、アジア太平洋市場は予測期間中最も速い速度で発展すると予想されます。

目次

第1章 世界の着床前遺伝子診断市場の定義と調査前提条件

  • 調査目的
  • 市場の定義
  • 調査前提条件
    • 包含と除外
    • 制限事項
    • 供給サイドの分析
      • 入手可能性
      • インフラ
      • 規制環境
      • 市場競争
      • 経済性（消費者の視点）
    • 需要サイド分析
      • 規制の枠組み
      • 技術の進歩
      • 環境への配慮
      • 消費者の意識と受容
  • 調査手法
  • 調査対象年
  • 通貨換算レート

第2章 エグゼクティブサマリー

  • 着床前遺伝子診断の世界市場規模・予測（2022年～2032年）
  • 地域別概要
  • セグメント別概要
    • 検査タイプ別
  • 主要動向
  • 不況の影響
  • アナリストの結論・提言

第3章 着床前遺伝子診断の世界市場力学

  • 市場促進要因
  • 市場の課題
  • 市場機会

第4章 着床前遺伝子診断の世界市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
    • ポーターのファイブフォースモデルへの未来的アプローチ
    • ポーターのファイブフォースの影響分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 着床前遺伝子診断の世界市場規模・予測：検査タイプ別、2022年～2032年

  • 染色体異常
  • 異数性
  • X連鎖性疾患
  • 単一遺伝子疾患
  • HLAタイピング
  • 性別選択
  • その他

第6章 着床前遺伝子診断の世界市場規模・予測：地域別、2022年～2032年

  • 北米の着床前遺伝子診断市場
    • 米国
      • 検査タイプの内訳規模・予測、2022-2032年
    • カナダの着床前遺伝子診断市場
  • 欧州の着床前遺伝子診断市場
    • 英国の着床前遺伝子診断市場
    • ドイツの着床前遺伝子診断市場
    • フランスの着床前遺伝子診断市場
    • スペインの着床前遺伝子診断市場
    • イタリアの着床前遺伝子診断市場
    • その他欧州の着床前遺伝子診断市場
  • アジア太平洋の着床前遺伝子診断市場
    • 中国の着床前遺伝子診断市場
    • インドの着床前遺伝子診断市場
    • 日本の着床前遺伝子診断市場
    • オーストラリアの着床前遺伝子診断市場
    • 韓国の着床前遺伝子診断市場
    • その他アジア太平洋地域の着床前遺伝子診断市場
  • ラテンアメリカの着床前遺伝子診断市場
    • ブラジルの着床前遺伝子診断市場
    • メキシコの着床前遺伝子診断市場
    • その他ラテンアメリカの着床前遺伝子診断市場
  • 中東・アフリカの着床前遺伝子診断市場
    • サウジアラビアの着床前遺伝子診断市場
    • 南アフリカの着床前遺伝子診断市場
    • その他中東とアフリカの着床前遺伝子診断市場

第7章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Natera Inc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 市場戦略
    • Agilent Technologies, Inc.
    • Reproductive Genetic Innovations, LLC
    • PerkinElmer, Inc.
    • Pacgenomics Inc
    • Quest Diagnostics Inc.
    • Laboratory Corporation of America Holdings
    • Cegat Gmbh
    • Invitae Corp.
    • Illumina Inc.

第8章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
図表

LIST OF TABLES

  • TABLE 1. Global Preimplantation Genetic Diagnosis market, report scope
  • TABLE 2. Global Preimplantation Genetic Diagnosis market estimates & forecasts by Region 2022-2032 (USD Million)
  • TABLE 3. Global Preimplantation Genetic Diagnosis market estimates & forecasts by Test Type 2022-2032 (USD Million)
  • TABLE 4. Global Preimplantation Genetic Diagnosis market by segment, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 5. Global Preimplantation Genetic Diagnosis market by region, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 6. Global Preimplantation Genetic Diagnosis market by segment, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 7. Global Preimplantation Genetic Diagnosis market by region, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 8. Global Preimplantation Genetic Diagnosis market by segment, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 9. Global Preimplantation Genetic Diagnosis market by region, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 10. Global Preimplantation Genetic Diagnosis market by segment, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 11. Global Preimplantation Genetic Diagnosis market by region, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 12. Global Preimplantation Genetic Diagnosis market by segment, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 13. Global Preimplantation Genetic Diagnosis market by region, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 14. U.S. Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 15. U.S. Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 16. U.S. Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 17. Canada Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 18. Canada Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 19. Canada Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 20. UK Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 21. UK Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 22. UK Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 23. Germany Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 24. Germany Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 25. Germany Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 26. France Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 27. France Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 28. France Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 29. Italy Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 30. Italy Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 31. Italy Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 32. Spain Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 33. Spain Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 34. Spain Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 35. RoE Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 36. RoE Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 37. RoE Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 38. China Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 39. China Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 40. China Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 41. India Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 42. India Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 43. India Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 44. Japan Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 45. Japan Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 46. Japan Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 47. Australia Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 48. Australia Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 49. Australia Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 50. South Korea Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 51. South Korea Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 52. South Korea Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 54. RoAPAC Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 55. RoAPAC Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 56. RoAPAC Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 57. Brazil Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 58. Brazil Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 59. Brazil Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 60. Mexico Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 61. Mexico Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 62. Mexico Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 63. RoLA Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 64. RoLA Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 65. RoLA Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 66. Saudi Arabia Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 67. Saudi Arabia Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 68. Saudi Arabia Preimplantation Genetic Diagnosis market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 69. South Africa Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 71. South Africa Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 72. South Africa Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 73. RoMEA Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 74. RoMEA Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 75. RoMEA Preimplantation Genetic Diagnosis market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 76. List of secondary sources, used in the study of Global Preimplantation Genetic Diagnosis Market.
  • TABLE 77. List of primary sources, used in the study of Global Preimplantation Genetic Diagnosis Market.
  • TABLE 78. Years considered for the study.
  • TABLE 79. Exchange rates considered.

LIST OF FIGURES

  • FIG 1. Global Preimplantation Genetic Diagnosis market, research methodology
  • FIG 2. Global Preimplantation Genetic Diagnosis market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods.
  • FIG 4. Global Preimplantation Genetic Diagnosis market, key trends 2023
  • FIG 5. Global Preimplantation Genetic Diagnosis market, growth prospects 2022-2032
  • FIG 6. Global Preimplantation Genetic Diagnosis market, porters 5 force model
  • FIG 7. Global Preimplantation Genetic Diagnosis market, pestel analysis
  • FIG 8. Global Preimplantation Genetic Diagnosis market, value chain analysis
  • FIG 9. Global Preimplantation Genetic Diagnosis market by segment, 2022 & 2032 (USD Million)
  • FIG 10. Global Preimplantation Genetic Diagnosis market by segment, 2022 & 2032 (USD Million)
  • FIG 11. Global Preimplantation Genetic Diagnosis market by segment, 2022 & 2032 (USD Million)
  • FIG 12. Global Preimplantation Genetic Diagnosis market by segment, 2022 & 2032 (USD Million)
  • FIG 13. Global Preimplantation Genetic Diagnosis market by segment, 2022 & 2032 (USD Million)
  • FIG 14. Global Preimplantation Genetic Diagnosis market, regional snapshot 2022 & 2032
  • FIG 15. North America Preimplantation Genetic Diagnosis market 2022 & 2032 (USD Million)
  • FIG 16. Europe Preimplantation Genetic Diagnosis market 2022 & 2032 (USD Million)
  • FIG 17. Asia pacific Preimplantation Genetic Diagnosis market 2022 & 2032 (USD Million)
  • FIG 18. Latin America Preimplantation Genetic Diagnosis market 2022 & 2032 (USD Million)
  • FIG 19. Middle East & Africa Preimplantation Genetic Diagnosis market 2022 & 2032 (USD Million)
  • FIG 20. Global Preimplantation Genetic Diagnosis market, company market share analysis (2023)
目次

Global Preimplantation Genetic Diagnosis Market is valued at approximately USD 72.12 million in 2023 and is anticipated to grow with a healthy growth rate of more than 11.41% over the forecast period 2024-2032. Preimplantation Genetic Diagnosis (PGD) is a sophisticated reproductive technology used with In Vitro Fertilization (IVF) to screen embryos for genetic conditions before implantation. This process helps couples at risk of passing on inherited genetic disorders increase their chances of having a healthy child. The IVF process involves hormonal treatments, egg retrieval, fertilization in a lab, and embryo culture to the blastocyst stage, where cells are biopsied and analyzed for genetic abnormalities. Embryos without defects are selected for transfer into the uterus. PGD reduces the transmission of genetic disorders, increases IVF success rates, and raises ethical considerations. It is beneficial for couples with a family history of genetic disorders, recurrent miscarriages, or fertility issues. The Global Preimplantation Genetic Diagnosis Market is growing due to increasing awareness of genetic disorders, advancements in reproductive technologies, rising acceptance of IVF procedures, and supportive government regulations. The trend of delayed parenthood and rising infertility rates also contribute to the demand for PGD, driving market growth.

The Global Preimplantation Genetic Diagnosis (PGD) market is driven by increasing awareness of genetic disorders, advancements in reproductive technologies, rising prevalence of inherited conditions, and growing acceptance of IVF procedures. Technological innovations, such as next-generation sequencing, have improved PGD's accuracy and efficiency, enabling broader detection of genetic abnormalities and reducing implantation failure and miscarriage risks. These advancements make PGD more reliable and accessible, encouraging more couples to use this technology for healthier offspring. However, high costs, ethical concerns regarding embryo selection, and the psychological impact on parents are significant barriers. Additionally, limited access to advanced reproductive technologies in developing regions and varying legal and ethical guidelines across countries pose challenges. Despite these, the supportive government regulations and funding for genetic research contribute to market growth, making PGD a valuable tool for ensuring the health of future generations.

The key regions considered for the Global Preimplantation Genetic Diagnosis market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the dominating region in terms of revenue in the Global Preimplantation Genetic Diagnosis (PGD) Market. The region boasts advanced healthcare infrastructure, allowing for widespread access to cutting-edge reproductive technologies. High adoption rates of PGD and IVF procedures are driven by increasing awareness of genetic disorders and the benefits of early genetic screening among prospective parents. Significant investments in research and development, coupled with supportive government policies and funding, foster continuous innovation and improvement in genetic testing methods. The presence of leading biotechnology companies and top-tier fertility clinics further enhances North America's market position. On the other hand, the market in Asia Pacific is expected to develop at the fastest rate over the forecast period.

Major market players included in this report are:

  • Natera Inc.
  • Agilent Technologies, Inc.
  • Reproductive Genetic Innovations, LLC
  • PerkinElmer, Inc.
  • Pacgenomics Inc
  • Quest Diagnostics Inc.
  • Laboratory Corporation of America Holdings,
  • Cegat Gmbh
  • Invitae Corp.
  • Illumina Inc.

The detailed segments and sub-segments of the market are explained below:

By Test Type

  • Chromosomal Abnormalities
  • Aneuploidy
  • X-linked diseases
  • Single Gene Disorders
  • HLA Typing
  • Gender selection
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Preimplantation Genetic Diagnosis Market Definition and Research Assumptions

  • 1.1. Research Objective
  • 1.2. Market Definition
  • 1.3. Research Assumptions
    • 1.3.1. Inclusion & Exclusion
    • 1.3.2. Limitations
    • 1.3.3. Supply Side Analysis
      • 1.3.3.1. Availability
      • 1.3.3.2. Infrastructure
      • 1.3.3.3. Regulatory Environment
      • 1.3.3.4. Market Competition
      • 1.3.3.5. Economic Viability (Consumer's Perspective)
    • 1.3.4. Demand Side Analysis
      • 1.3.4.1. Regulatory frameworks
      • 1.3.4.2. Technological Advancements
      • 1.3.4.3. Environmental Considerations
      • 1.3.4.4. Consumer Awareness & Acceptance
  • 1.4. Estimation Methodology
  • 1.5. Years Considered for the Study
  • 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

  • 2.1. Global Preimplantation Genetic Diagnosis Market Size & Forecast (2022- 2032)
  • 2.2. Regional Summary
  • 2.3. Segmental Summary
    • 2.3.1. By Test Type
  • 2.4. Key Trends
  • 2.5. Recession Impact
  • 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Preimplantation Genetic Diagnosis Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Challenges
  • 3.3. Market Opportunities

Chapter 4. Global Preimplantation Genetic Diagnosis Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Preimplantation Genetic Diagnosis Market Size & Forecasts by Test Type 2022-2032

  • 5.1. Chromosomal Abnormalities
  • 5.2. Aneuploidy
  • 5.3. X-linked diseases
  • 5.4. Single Gene Disorders
  • 5.5. HLA Typing
  • 5.6. Gender selection
  • 5.7. Others

Chapter 6. Global Preimplantation Genetic Diagnosis Market Size & Forecasts by Region 2022-2032

  • 6.1. North America Preimplantation Genetic Diagnosis Market
    • 6.1.1. U.S. Preimplantation Genetic Diagnosis Market
      • 6.1.1.1. Test Type breakdown size & forecasts, 2022-2032
    • 6.1.2. Canada Preimplantation Genetic Diagnosis Market
  • 6.2. Europe Preimplantation Genetic Diagnosis Market
    • 6.2.1. U.K. Preimplantation Genetic Diagnosis Market
    • 6.2.2. Germany Preimplantation Genetic Diagnosis Market
    • 6.2.3. France Preimplantation Genetic Diagnosis Market
    • 6.2.4. Spain Preimplantation Genetic Diagnosis Market
    • 6.2.5. Italy Preimplantation Genetic Diagnosis Market
    • 6.2.6. Rest of Europe Preimplantation Genetic Diagnosis Market
  • 6.3. Asia-Pacific Preimplantation Genetic Diagnosis Market
    • 6.3.1. China Preimplantation Genetic Diagnosis Market
    • 6.3.2. India Preimplantation Genetic Diagnosis Market
    • 6.3.3. Japan Preimplantation Genetic Diagnosis Market
    • 6.3.4. Australia Preimplantation Genetic Diagnosis Market
    • 6.3.5. South Korea Preimplantation Genetic Diagnosis Market
    • 6.3.6. Rest of Asia Pacific Preimplantation Genetic Diagnosis Market
  • 6.4. Latin America Preimplantation Genetic Diagnosis Market
    • 6.4.1. Brazil Preimplantation Genetic Diagnosis Market
    • 6.4.2. Mexico Preimplantation Genetic Diagnosis Market
    • 6.4.3. Rest of Latin America Preimplantation Genetic Diagnosis Market
  • 6.5. Middle East & Africa Preimplantation Genetic Diagnosis Market
    • 6.5.1. Saudi Arabia Preimplantation Genetic Diagnosis Market
    • 6.5.2. South Africa Preimplantation Genetic Diagnosis Market
    • 6.5.3. Rest of Middle East & Africa Preimplantation Genetic Diagnosis Market

Chapter 7. Competitive Intelligence

  • 7.1. Key Company SWOT Analysis
  • 7.2. Top Market Strategies
  • 7.3. Company Profiles
    • 7.3.1. Natera Inc.
      • 7.3.1.1. Key Information
      • 7.3.1.2. Overview
      • 7.3.1.3. Financial (Subject to Data Availability)
      • 7.3.1.4. Product Summary
      • 7.3.1.5. Market Strategies
    • 7.3.2. Agilent Technologies, Inc.
    • 7.3.3. Reproductive Genetic Innovations, LLC
    • 7.3.4. PerkinElmer, Inc.
    • 7.3.5. Pacgenomics Inc
    • 7.3.6. Quest Diagnostics Inc.
    • 7.3.7. Laboratory Corporation of America Holdings
    • 7.3.8. Cegat Gmbh
    • 7.3.9. Invitae Corp.
    • 7.3.10. Illumina Inc.

Chapter 8. Research Process

  • 8.1. Research Process
    • 8.1.1. Data Mining
    • 8.1.2. Analysis
    • 8.1.3. Market Estimation
    • 8.1.4. Validation
    • 8.1.5. Publishing
  • 8.2. Research Attributes